|
DDX23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.628000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.306200E-01 |
| Normal-vs-Stage2 |
5.631200E-01 |
| Normal-vs-Stage3 |
2.542600E-01 |
| Normal-vs-Stage4 |
3.683600E-01 |
| Stage1-vs-Stage2 |
8.329700E-02 |
| Stage1-vs-Stage3 |
7.823700E-03 |
| Stage1-vs-Stage4 |
1.890260E-02 |
| Stage2-vs-Stage3 |
7.023800E-01 |
| Stage2-vs-Stage4 |
8.189400E-01 |
| Stage3-vs-Stage4 |
8.587600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.864400E-01 |
| Normal-vs-AfricanAmerican |
7.626400E-01 |
| Normal-vs-Asian |
2.558200E-02 |
| Caucasian-vs-AfricanAmerican |
7.137400E-01 |
| Caucasian-vs-Asian |
4.192400E-02 |
| AfricanAmerican-vs-Asian |
6.843700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.986000E-01 |
| Normal-vs-Female |
7.324200E-01 |
| Male-vs-Female |
5.263000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.651800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.499600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.575000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.120980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.379000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.355600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.174200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.570200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.008300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.026820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.685900E-02 |
| Normal-vs-Grade 2 |
4.307600E-01 |
| Normal-vs-Grade 3 |
7.101600E-01 |
| Normal-vs-Grade 4 |
2.384800E-01 |
| Grade 1-vs-Grade 2 |
7.492300E-02 |
| Grade 1-vs-Grade 3 |
1.249670E-02 |
| Grade 1-vs-Grade 4 |
4.142700E-03 |
| Grade 2-vs-Grade 3 |
1.126750E-01 |
| Grade 2-vs-Grade 4 |
3.123900E-02 |
| Grade 3-vs-Grade 4 |
3.114800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.879620E-01 |
| Normal-vs-ccB subtype |
5.637400E-01 |
| ccA subtype-vs-ccB subtype |
2.050200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.979000E-01 |
| Normal-vs-N1 |
6.750200E-01 |
| N0-vs-N1 |
6.054600E-01 |
|
|
